- Rapid microfluidic immunofluorescence assay for use with the LumiraDx Platform intended for the simultaneous detection and differentiation of SARS-CoV-2, influenza A, and influenza B viral antigen - ...
ClearNote Health’s Avantect Pancreatic Cancer Test has secured the UK Conformity Assessed (UKCA) marking, signifying compliance with medical device regulations in the UK. This approval marks a step ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--The first diagnostic designed to identify patients with long COVID has received CE-IVD marking in Europe. It is ready for its formal launch in countries accepting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results